MedTrace Logo

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

NCT04847895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5500

Last updated 2021-04-19

No results posted yet for this study

Summary

This study is designed as an observational, non-interventional, multicenter, open label, single arm study in patients being treated with Lucentis® for any approved indication included in the local product posology.

Conditions

Interventions

DRUG

Lucentis

There is no treatment allocation. Patients administered Lucentis by prescription that have started before inclusion of the patient into the study will be enrolled.

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • Germany
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04847895 on ClinicalTrials.gov